| Human Molecular Genetics | Pages |
Genome-wide scan for autism susceptibility genes
Introduction
Results
Discussion
Materials And Methods
Families
Genotyping
Linkage analysis
Acknowledgements
References
Genome-wide scan for autism susceptibility genes
INTRODUCTION
Autism (MIM 209850) is an aetiologically heterogeneous syndrome. Approximately 10-25% of autism cases are due to known medical conditions, involving environmental factors or genetic disorders (1,2). The cause remains unknown in the other cases. The risk of developing autism is ~50-100 times greater for siblings of autistic individuals than for the general population (3). Twin studies have shown a much higher concordance for monozygotic than for dizygotic twins, suggesting a strong genetic component to autism (4). Candidate gene studies with family-based case controls have demonstrated linkage disequilibrium between autism and a marker in the [gamma]-aminobutyric acidA receptor subunit gene (GABRB3), and between autism and polymorphisms of the serotonin transporter gene (5-HTT) (5-7). The first genome-wide screen for autism, conducted by the International Molecular Genetic Study of Autism Consortium (IMGSAC), has suggested the involvement of six different chromosomal regions (4, 7, 10, 16, 19 and 22) (8). We undertook a full genome-wide screen for autism susceptibility loci, using the non-parametric sib-pair method in 51 multiplex families.
RESULTS
Fifty-one families (described in Table 1) including at least two siblings or half-siblings affected by autism were recruited. Full genotype information was available for all parents except four fathers. All the families were Caucasian, 18 were from Sweden (35%), 15 from France (29%), six from Norway (12%), five from the USA (10%), three from Italy (6%), two from Austria (4%) and two from Belgium (4%). The mean age of the probands was 13.5 years (4-44) and the sex ratio was 2.85 (77 boys and 27 girls). The non-verbal IQ distribution was: IQ >70 for 12.5% of the patients, between 50 and 70 for 30.5%, and <50 for 57%.
Table 1.
| Number of families Autosomal screening |
X chromosome screening | |
|---|---|---|
| Two affected siblings | 47 | 47 |
| Two affected siblings: two half-siblings | 0 | 2 |
| Three affected siblings | 1 | 1 |
| Three affected siblings: two full and one half-sibling | 1 | 1 |
| Total number of affected sib-pairs | 51 | 55 |
| Sex of affected sib-pairs | ||
| Male/male | 25 | 29 |
| Male/female | 22 | 22 |
| Female/female | 4 | 4 |
Table 2.
| Locus | Position (cM)a | Two-point analysis | Multipoint analysis | ||
|---|---|---|---|---|---|
| MLS | P-value | MLSb (% IBD sharing) | P-value | ||
| D2S382 | 210.4 | 0.98 | 0.0160 | ||
| PEAK 2 | 223.1 | 0.64 (62.7) | 0.0659 | ||
| D2S364 | 231.5 | 0.65 | 0.0400 | ||
| PEAK 4 | 226.1 | 0.88 (61.0) | 0.0352 | ||
| D4S1535 | 226.1 | 0.92 | 0.0199 | ||
| D5S417 | 0.0 | 0.75 | 0.0315 | ||
| PEAK 5 | 0.0 | 0.84 (61.3) | 0.0391 | ||
| D6S283 | 128.0 | 1.02 | 0.0149 | ||
| PEAK 6 | 132.8 | 2.23 (68.6) | 0.0013 | ||
| PEAK 7 | 135.3 | 0.83 (59.0) | 0.0401 | ||
| D7S486 | 135.3 | 0.52 | 0.0609 | ||
| D10S217 | 196.9 | 0.61 | 0.0460 | ||
| PEAK 10 | 212.0 | 0.84 (66.0) | 0.0391 | ||
| D15S128 | 0.0 | 0.66 | 0.0402 | ||
| PEAK 15 | 41.1 | 1.10 (63.0) | 0.0201 | ||
| D15S118 | 41.1 | 0.76 | 0.0305 | ||
| D16S3075 | 10.6 | 0.62 | 0.0456 | ||
| PEAK 16 | 17.1 | 0.74 (60.5) | 0.0506 | ||
| D18S68 | 60.0 | 1.47 | 0.0046 | ||
| PEAK 18 | 60.0 | 0.62 (58.5) | 0.0695 | ||
| D19S226 | 24.1 | 1.17 | 0.0102 | ||
| PEAK 19 | 24.1 | 1.37 (61.9) | 0.0103 | ||
| DXS996 | 0.0 | 0.89 | 0.0210 | ||
| PEAK X | 0.0 | 0.40 (60.0) | 0.0900 | ||
The results of two-point affected sib-pair analysis (SIBPAIR) are summarized in Table 2. A maximum lod score (MLS) >0.6 (nominal P < 0.05) was obtained for 12 of the 264 (4.5%) markers tested on chromosomes 2, 4, 5, 6, 10, 15, 16, 18, 19 and X. The highest two-point MLS values were for chromosomes 18 (D18S68, MLS = 1.47, P = 0.0046), 19 (D19S226, MLS = 1.17, P = 0.0102) and 6 (D6S283, MLS = 1.02, P = 0.0149).
|
Figure 1. Multipoint MLS values at each point location for each chromosome. These potential regions were also significant at the 5% level in multipoint analysis except for those on chromosomes 2 (P = 0.0659), 18 (P = 0.0695) and X (P = 0.0900) (Fig.
DISCUSSION
Our genome-wide scan revealed 11 chromosomal regions positively linked to autism with nominal P-values of 5% or lower. The multitests problem of these linkage analyses raises the challenging issue of what constitutes a statistically significant finding (9-11). It is also argued that to localize a gene and to replicate its localization require different criteria for significance (9,12). Nonetheless, there is agreement that replication studies are essential to distinguish true from false-positive linkage findings. Our study is, to our knowledge, the first replication study of the IMGSAC findings, the first genome-wide scan of autism (8). Using the genome-wide thresholds derived by Lander and Krugylak (9), none of our positive findings constitutes a `significant' linkage (i.e. P < 2.2 × 10-5). In our independent sample of autism families, the number of markers significant at the 5% level is close to that expected by chance (13 out of 264). Although the statistical inference is weaker, some of our positive findings show, however, evidence consistent with excess sharing in regions reported by other candidate gene studies or by the IMGSAC group.
Four regions, on chromosomes 2q, 7q, 16p and 19p were identified that overlapped with those reported by the IMGSAC study. Two of these four regions gave the most significant scores in the IMGSAC study: chromosome regions 7q and 16p had peak MLS values of 3.55 and 1.97, respectively, in the English subgroup of 56 affected sib-pair families. However, for the total sample of 87 families, the evidence for linkage of autism to these regions was weaker (MLS = 2.53 and 1.51, respectively) (8). Interestingly, the proband of one affected sib-pair in our initial recruitment was excluded due to microduplication of 16p13. Another patient with autism and partial duplication of 16p has been reported (13). These data reinforce the hypothesis that a susceptibility locus for autism maps on chromosome 16p.
On the other hand, the present study did not replicate three positive results reported by IMGSAC. We found no evidence for excess of alleles shared identical by descent (IBD) on chromosomes 4p, 10p or 22p. There may be several reasons for these conflicting results: false-negative results due to our smaller sample size, false-positive results, genetic heterogeneity between data sets within or between studies, or differences in the diagnostic criteria used in the two studies. We evaluated the power of our family data set (given the observed family structures: sibship sizes, number of affected and unaffected sibs, and DNA availability) to detect an excess of marker alleles IBD sharing ( y) of 64 and 59%, corresponding to a locus-specific sibling recurrence risk ([lambda]s) of ~2 or 1.6, respectively. These are the values estimated in the total IMGSAC family data from the most significant findings, i.e. chromosomes 7q and 16p markers. Power estimates of our data set (rate of significant replicates out of 2000) were evaluated for different maximum MLS values (data not shown). Our family sample has good power to detect linkage when [lambda]s is [ge]2. Weaker genetic effects, as expected, are unlikely to be found. For instance, to replicate a finding at the 5% level, the power of our data set is 81 or 44% when y = 64 or 59%, respectively.
We also identified a potential susceptibility region, with positive results for three adjacent markers, on chromosome 15 (q11-q15). This region included the critical imprinted region for Prader-Willi and Angelman syndromes. Pericak-Vance et al. (14) reported weak linkage with autism for an overlapping region, in 15q11.2-q13, for a sample of 37 multiplex families. Cook et al. (5) demonstrated linkage disequilibrium between autism and the [gamma]-aminobutyric acid receptor subunit gene GABRB3, which maps to 15q11.2-q12. Several case reports have also described chromosomal abnormalities of the 15q11-q13 region associated with autistic features (15-17).
Finally, our study revealed six other regions potentially involved in autism on chromosomes 4q, 5p, 6q, 10q, 18q and Xp. Excess of alleles shared IBD was most significant on chromosome 6q (MLS = 2.23, IBD = 68.6%). Based on estimated sharing probabilities (Z0 = 0.157, Z1 = 0.313, Z2 = 0.107), the 6q-specific [lambda]s was 1.59. Interestingly, Cao et al. (18) provided evidence for a schizophrenia susceptibility locus on 6q13-q26 in independent data sets. Possible candidate genes in this region include those for myristoylated alanine-rich protein kinase C substrate (MACS), which may be involved in the development of the central nervous system, glutamate receptor 6 (GRIK6) and G protein-coupled receptor 6 (GPR6), which is most strongly expressed in the putamen.
Fine mapping of the regions identified is under way. Nevertheless, because of the large number of tests in genome-wide approaches, these findings require confirmation on other independent panels of families.
MATERIALS AND METHODS
Families
Families with at least two siblings or half-siblings fulfilling the DSM IV criteria for autistic disorder (19) and the Autism Diagnostic Interview (ADI) algorithm for ICD-10 childhood autism (20) were recruited for an international collaborative autism sib-pair project, involving seven countries (Austria, Belgium, France, Italy, Norway, Sweden and the USA). Subjects were included only after thorough clinical and medical examinations comprising a full exploration of medical and family history, physical (including meticulous skin examination involving Wood's light assessment), neuropsychological [appropriate IQ test or Vineland interview (21)] and neurological examination, standard karyotyping and fragile-X testing (either karyotype in folic acid-depleted medium or molecular genetic testing for the trinucleotide repeat expansion in the FMR-1 gene), brain imaging and blood and urine analysis. Cases diagnosed in which there were associated organic conditions, such as phenylketonuria, tuberous sclerosis, neurofibromatosis, hypomelanosis of Ito, Rett syndrome, Moebius syndrome, Duchenne muscular dystrophy, Down's syndrome, fragile X syndrome or other established chromosomal disorders, were excluded. However, severe mental retardation, epilepsy, mild motor co-ordination disorders, mild hearing deficits, attention deficits and tics were not exclusion criteria. Blood samples were taken from affected siblings and both parents. The study was approved by the ethical committees of the collaborating organizations. Informed consent forms were completed by the parents of each child included in the study.
Genotyping
Blood samples were collected from both parents and affected sib-pairs. DNA was extracted and lymphoblastoid cell lines generated. If one parent was unavailable, blood samples were also taken from unaffected siblings to increase the probability of inferring the genotype of the missing parent.
A complete genomic screen was performed with 252 autosomal and 12 X-linked microsatellite markers in the Gnthon Laboratory (Evry, France) (22). We used fluorescent primers. Polymerase chain reaction (PCR) was performed in a total volume of 50 µl, containing 80 ng of genomic DNA, 50 pmol of each primer, 0.125 mM dNTPs and 1 U Taq polymerase. The amplification buffer (1×) contained 10 mM Tris base pH 9, 50 mM KCl, 1.5 mM MgCl2, 0.1% Triton X-100 and 0.01% gelatin. Reactions were performed using a hot-start procedure, with Taq polymerase added only after a first denaturation step of 5 min at 96°C. DNA was amplified in 35 cycles of denaturation (94°C for 40 s) and annealing (55°C for 30 s). An elongation step (72°C for 2 min) terminated the reaction after the last annealing. PCR products were combined into pools and typed using the semi-automated Genescan/Genotyper system on ABI 373A sequencing machines.
Linkage analysis
Non-parametric likelihood methods were used for linkage analysis. Pairwise linkage was conducted using the SIBPAIR program (23), which provides a likelihood-based test statistic for linkage. The likelihoods over all families are maximized as a function of the rate of marker alleles IBD ( y) among affected sibs, and the likelihood ratio test statistic T is calculated against the null hypothesis of y = 0.5 (T = 2Ln[L( y)/L( y = 0.5)]). The statistic follows a [chi]2 distribution with 1 degree of freedom and can thus be expressed as a lod score, MLS = T/2ln(10). Multipoint affected sib-pair linkage analysis, which uses information from all markers simultaneously, was performed using the program MAPMAKER/SIBS (24) which tests linkage by the maximum likelihood ratio approach (25). At any chromosomal location, the likelihood of the observed marker information among affected sib-pairs is maximized as a function of the proportion of pairs sharing two, one and zero alleles IBD, and is compared, through a likelihood ratio test, with the likelihood of the marker data under the null hypothesis of no linkage (i.e. T = 2Ln[L(Z2, Z1, Z0)/L(Z2 = 0.25, Z1 = 0.5, Z0 = 0.25)]). An evaluation of the [lambda]s attributed to a locus can be calculated as 0.25/Z0 (24). Holmans has shown that the power of the test is increased when imposing constraints among Z parameters such as the possible triangle test (2Z0 [le] Z1 and Z1 [le] 1/2) and that the resulting distribution of T is a mixture of [chi]2s with 1 and 2 degrees of freedom (26). The statistic can also be reported as a lod score: MLS = T/2ln(10). For X-chromosome marker data, the likelihood ratio test is a function of one parameter only (i.e. T = 2Ln[L(Z1, 1 - Z1)/L(Z1 = 0.5, Z0 = 0.5)]). The resulting distribution of T is a [chi]2 distribution with 1 degree of freedom. Because the X chromosome version of MAPMAKER/SIBS program is not functional, multipoint MLS values for X marker data were computed using the sib-phase program of ASPEX package (25,27).
ACKNOWLEDGEMENTS
We would like to thank the subjects and their families for their co-operation with this study. We are grateful to Armelle Faure and Nathalie Chron for technical help in the Gnthon Laboratory, and to Jacky Bou, Yolaine Pothin and Agns Camuzat for technical assistance in the INSERM U289 laboratory. This work was supported by the Assistance Publique-Hopitaux-de-Paris (PHRC AOM95076 and CRC no. 932413), the Association Franaise contre les Myopathies, the Fondation France-Telecom, the Fondation Lilly and the Swedish Medical Research Council (grant no. K97-21X-11251-03CK). A.P. was funded by a grant from the Fondation pour la Recherche Médicale.
REFERENCES
This article has been cited by other articles:
Sweden. Child Neuropsychiatry, Sahlgren University Hospital, S-413 45 Gsteburg: Christopher Gillberg, Maria R[OElig]stam, Carina Gillberg and Agneta Nyden.
This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: jnl.info{at}oup.co.uk
Last modification: 8 Apr 1999
Copyright©Oxford University Press, 1999.
![]()
CiteULike
Connotea
Del.icio.us What's this?
![]()
![]()

![]()
![]()
![]()
H. Kilpinen, T. Ylisaukko-oja, K. Rehnstrom, E. Gaal, J. A. Turunen, E. Kempas, L. von Wendt, T. Varilo, and L. Peltonen
Linkage and linkage disequilibrium scan for autism loci in an extended pedigree from Finland
Hum. Mol. Genet.,
August 1, 2009;
18(15):
2912 - 2921.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
A. I. Alvarez Retuerto, R. M. Cantor, J. G. Gleeson, A. Ustaszewska, W. S. Schackwitz, L. A. Pennacchio, and D. H. Geschwind
Association of common variants in the Joubert syndrome gene (AHI1) with autism
Hum. Mol. Genet.,
December 15, 2008;
17(24):
3887 - 3896.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
S. Xu, P. D. Witmer, S. Lumayag, B. Kovacs, and D. Valle
MicroRNA (miRNA) Transcriptome of Mouse Retina and Identification of a Sensory Organ-specific miRNA Cluster
J. Biol. Chem.,
August 24, 2007;
282(34):
25053 - 25066.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
J. A. Duvall, A. Lu, R. M. Cantor, R. D. Todd, J. N. Constantino, and D. H. Geschwind
A Quantitative Trait Locus Analysis of Social Responsiveness in Multiplex Autism Families
Am J Psychiatry,
April 1, 2007;
164(4):
656 - 662.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
M-L Jacquemont, D Sanlaville, R Redon, O Raoul, V Cormier-Daire, S Lyonnet, J Amiel, M Le Merrer, D Heron, M-C de Blois, et al.
Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders
J. Med. Genet.,
November 1, 2006;
43(11):
843 - 849.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
N. C. Schanen
Epigenetics of autism spectrum disorders
Hum. Mol. Genet.,
October 15, 2006;
15(suppl_2):
R138 - R150.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
T Sahoo, S U Peters, N S Madduri, D G Glaze, J R German, L M Bird, R Barbieri-Welge, T J Bichell, A L Beaudet, and C A Bacino
Microarray based comparative genomic hybridization testing in deletion bearing patients with Angelman syndrome: genotype-phenotype correlations
J. Med. Genet.,
June 1, 2006;
43(6):
512 - 516.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
R. Rabionet, J. L. McCauley, Ph.D., J. M. Jaworski, M.P.H., A. E. Ashley-Koch, E. R. Martin, J. S. Sutcliffe, J. L. Haines, G. R. DeLong, R. K. Abramson, H. H. Wright, et al.
Lack of Association Between Autism and SLC25A12
Am J Psychiatry,
May 1, 2006;
163(5):
929 - 931.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
V. Wong
Study of the Relationship Between Tuberous Sclerosis Complex and Autistic Disorder
J Child Neurol,
March 1, 2006;
21(3):
199 - 204.
[Abstract]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
S. S.M. Ng, B. K.C. Chow, and V. C.N. Wong
The Human Secretin Gene in Children With Autistic Spectrum Disorder: Screening for Polymorphisms and Mutations
J Child Neurol,
August 1, 2005;
20(8):
701 - 704.
[Abstract]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
R. C. Samaco, A. Hogart, and J. M. LaSalle
Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3
Hum. Mol. Genet.,
February 15, 2005;
14(4):
483 - 492.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
D. A. Schwartz, J. H. Freedman, and E. A. Linney
Environmental genomics: a key to understanding biology, pathophysiology and disease
Hum. Mol. Genet.,
October 1, 2004;
13(suppl_2):
R217 - R224.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
B. Chih, S. K. Afridi, L. Clark, and P. Scheiffele
Disorder-associated mutations lead to functional inactivation of neuroligins
Hum. Mol. Genet.,
July 15, 2004;
13(14):
1471 - 1477.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
L. T.-O. Lee, K.-C. Tan-Un, R. T.-K. Pang, D. T.-W. Lam, and B. K.-C. Chow
Regulation of the Human Secretin Gene Is Controlled by the Combined Effects of CpG Methylation, Sp1/Sp3 Ratio, and the E-Box Element
Mol. Endocrinol.,
July 1, 2004;
18(7):
1740 - 1755.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
D. Castermans, V. Wilquet, J. Steyaert, W. van de Ven, J.-P. Fryns, and K. Devriendt
Chromosomal Anomalies in Individuals with Autism: A Strategy towards the Identification of Genes Involved in Autism
Autism,
June 1, 2004;
8(2):
141 - 161.
[Abstract]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
F. J. Serajee, R. Nabi, Hailang Zhong, and A.H.M. Mahbubul Huq
Polymorphisms in Xenobiotic Metabolism Genes and Autism
J Child Neurol,
June 1, 2004;
19(6):
413 - 417.
[Abstract]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
M S Yang, L Yu, T W Guo, S M Zhu, H J Liu, Y Y Shi, N-F Gu, G Y Feng, and L He
Evidence for association between single nucleotide polymorphisms in T complex protein 1 gene and schizophrenia in the Chinese Han population
J. Med. Genet.,
May 1, 2004;
41(5):
e63 - e63.
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
R. Muhle, S. V. Trentacoste, and I. Rapin
The Genetics of Autism
Pediatrics,
May 1, 2004;
113(5):
e472 - e486.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
F J Serajee, R Nabi, H Zhong, and A H M Mahbubul Huq
Association of INPP1, PIK3CG, and TSC2 gene variants with autistic disorder: implications for phosphatidylinositol signalling in autism
J. Med. Genet.,
November 1, 2003;
40(11):
e119 - 119.
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
F J Serajee, H Zhong, R Nabi, and A H M M. Huq
The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism
J. Med. Genet.,
April 1, 2003;
40(4):
e42 - 42.
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
H Zhong, F J Serajee, R Nabi, and A H M M. Huq
No association between the EN2 gene and autistic disorder
J. Med. Genet.,
January 1, 2003;
40(1):
e4 - 4.
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
C. J. Newschaffer, D. Fallin, and N. L. Lee
Heritable and Nonheritable Risk Factors for Autism Spectrum Disorders
Epidemiol. Rev.,
December 1, 2002;
24(2):
137 - 153.
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
Z Talebizadeh, D C Bittel, J H Miles, N Takahashi, C H Wang, N Kibiryeva, and M G Butler
No association between HOXA1 and HOXB1 genes and autism spectrum disorders (ASD)
J. Med. Genet.,
November 1, 2002;
39(11):
e70 - 70.
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
C-H Tsai, S L Graw, and L McGavran
8p23 duplication reconsidered: is it a true euchromatic variant with no clinical manifestation?
J. Med. Genet.,
October 1, 2002;
39(10):
769 - 774.
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
I Borg, M Squire, C Menzel, K Stout, D Morgan, L Willatt, P C M O'Brien, M A Ferguson-Smith, H H Ropers, N Tommerup, et al.
A cryptic deletion of 2q35 including part of the PAX3 gene detected by breakpoint mapping in a child with autism and a de novo 2;8 translocation
J. Med. Genet.,
June 1, 2002;
39(6):
391 - 399.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
W.-H. Yung, P.-S. Leung, S. S. M. Ng, J. Zhang, S. C. Y. Chan, and B. K. C. Chow
Secretin Facilitates GABA Transmission in the Cerebellum
J. Neurosci.,
September 15, 2001;
21(18):
7063 - 7068.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
P. J. ASHERSON and S. CURRAN
Approaches to gene mapping in complex disorders and their application in child psychiatry and psychology
The British Journal of Psychiatry,
August 1, 2001;
179(2):
122 - 128.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
A. W. Sailer, H. Sano, Z. Zeng, T. P. McDonald, J. Pan, S.-S. Pong, S. D. Feighner, C. P. Tan, T. Fukami, H. Iwaasa, et al.
Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R
PNAS,
June 7, 2001;
(2001)
121170598.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
E. Asano, H. Kuivaniemi, A.H.M. Mahbubul Huq, G. Tromp, M. Behen, R. Rothermel, J. Herron, and D. C. Chugani
A Study of Novel Polymorphisms in the Upstream Region of Vasoactive Intestinal Peptide Receptor Type 2 Gene in Autism
J Child Neurol,
May 1, 2001;
16(5):
357 - 363.
[Abstract]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
L. Khare, G. D Strizheva, J. N Bailey, K.-S. Au, H. Northrup, M. Smith, S. L Smalley, and E. P. Henske
A novel missense mutation in the GTPase activating protein homology region of TSC2 in two large families with tuberous sclerosis complex
J. Med. Genet.,
May 1, 2001;
38(5):
347 - 349.
[Full Text]
![]()
![]()
![]()

![]()
![]()
![]()
International Molecular Genetic Study of Autism Co
Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q
Hum. Mol. Genet.,
April 1, 2001;
10(9):
973 - 982.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
R. J. Daniels, J. F. Peden, C. Lloyd, S. W. Horsley, K. Clark, C. Tufarelli, L. Kearney, V. J. Buckle, N. A. Doggett, J. Flint, et al.
Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16
Hum. Mol. Genet.,
February 1, 2001;
10(4):
339 - 352.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
M. Maziade, C. Merette, M. Cayer, M.-A. Roy, P. Szatmari, R. Cote, and J. Thivierge
Prolongation of Brainstem Auditory-Evoked Responses in Autistic Probands and Their Unaffected Relatives
Arch Gen Psychiatry,
November 1, 2000;
57(11):
1077 - 1083.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
J. A. Lamb, J. Moore, A. Bailey, and A. P. Monaco
Autism: recent molecular genetic advances
Hum. Mol. Genet.,
April 1, 2000;
9(6):
861 - 868.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
A. W. Sailer, H. Sano, Z. Zeng, T. P. McDonald, J. Pan, S.-S. Pong, S. D. Feighner, C. P. Tan, T. Fukami, H. Iwaasa, et al.
Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R
PNAS,
June 19, 2001;
98(13):
7564 - 7569.
[Abstract]
[Full Text]
[PDF]
![]()
This Article ![]()
![]()
Abstract
![]()
FREE Full Text (PDF)
![]()
Alert me when this article is cited
![]()
Alert me if a correction is posted
![]()
Services ![]()
![]()
Email this article to a friend
![]()
Similar articles in this journal
![]()
Similar articles in ISI Web of Science
![]()
Similar articles in PubMed
![]()
Alert me to new issues of the journal
![]()
Add to My Personal Archive
![]()
Download to citation manager
![]()
Search for citing articles in:
ISI Web of Science (298)
![]()
Request Permissions ![]()
Google Scholar ![]()
![]()
Articles by Philippe, A.
![]()
Articles by Leboyer, M.
![]()
Search for Related Content
![]()
PubMed ![]()
![]()
PubMed Citation
![]()
Articles by Philippe, A.
![]()
Articles by Leboyer, M.
![]()
Social Bookmarking ![]()
![]()
What's this?


